How does estrogen therapy influence urinary incontinence in postmenopausal women?

• A. Estrogen cures stress urinary incontinence completely
• B. Local vaginal estrogen can improve tissue quality and may modestly improve SUI symptoms; systemic estrogen can have variable effects; often used as adjunct
• C. Estrogen worsens all urinary symptoms
• D. Estrogen has no role in postmenopausal urinary incontinence

Answer: (B)

Estrogen helps by improving the health of the tissues in the urogenital area. After menopause, thinning and fragility of the vaginal and urethral mucosa reduce tissue coaptation and urethral closure, making leakage with coughing or other activities more likely. Local vaginal estrogen (creams, tablets, rings) thickens the epithelium, increases blood flow, and enhances lubrication and tissue quality around the urethra. This can modestly improve leakage symptoms related to stress incontinence, especially when vaginal atrophy is a contributing factor. Systemic estrogen, on the other hand, shows variable effects on continence—some women notice little or no improvement, and effects can differ from person to person. Because of that variability, systemic estrogen is not relied upon as a primary treatment for stress incontinence and is often used as an adjunct for genitourinary symptoms. In short, local estrogen can improve tissue quality and may modestly help SUI; systemic estrogen effects are inconsistent, so it’s not a mainstay treatment for incontinence.